Article

Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework

2021-10-03

Abstract excerpt

<h4>ABSTRACT</h4> Thrombosis and Thromobocytopenia Syndrome (TTS) has been associated with the AstraZencea (AZ) COVID-19 vaccine. Australia has reported low TTS incidence of <3/100,000 after the first dose, with case fatality rate (CFR) of 5-6%. Risk-benefit analysis of vaccination has been challenging because of rapidly evolving data, changing levels of transmission, and age-specific variation in rates of TTS, CO...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0385e865-44f9-5465-81b3-92a84d558691
DOI: 10.1101/2021.09.30.21264337

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling frameworkDOI 10.1101/2021.09.30.21264337Read

Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccineSemantic proximity Read

COVID-19 vaccine-associated cerebral venous thrombosis in GermanySemantic proximity Read

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysisSemantic proximity Read

Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - an ACCESS Cohort StudySemantic proximity Read

Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - An ACCESS Cohort StudySemantic proximity Read

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesSemantic proximity Read

Impact of vaccination on the association of COVID-19 with arterial and venous thrombotic diseases: an OpenSAFELY cohort study using linked electronic health recordsSemantic proximity Read

Thrombosis of Transverse Cerebral Venous Sinus Secondary to Vaccine ChAdOx1-S (Recombinant) First Report in SouthamericaSemantic proximity Read

Arterial and Venous Thrombosis in COVID-19 Disease: From Molecular Pathway to Vaccine AdministrationSemantic proximity Read

Cohort monitoring of 29 Adverse Events of Special Interest prior to and after COVID-19 vaccination in four large European electronic healthcare data sourcesSemantic proximity Read

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?Semantic proximity Read

An agent-based model of dengue virus transmission shows how multiple uncertainties about vaccine efficacy influence public health impact projectionsSemantic proximity Read